期刊
NEURODEGENERATIVE DISEASE MANAGEMENT
卷 7, 期 6, 页码 35-40出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nmt-2017-0040
关键词
brain; exercise therapy; multiple sclerosis; walking
资金
- Biogen Idec
- Merck Serono
- Sanofi Aventis
- Bayer Schering
- Novartis
- Sanofi Genzyme
- Almirall SA (Barcelona, Spain)
Exercise therapy is a promising nonpharmacological therapy in people with multiple sclerosis (MS). Although exercise training may induce a transient worsening of symptoms in some MS patients, it is generally considered safe and does not increase the risk of relapses. Exercise training can lead to clinically relevant improvements in physical function, but should be considered an adjunct to specific task-based training. Exercise has also shown positive effects on the brain, including improvements in brain volume and cognition. In summary, exercise therapy is a safe and potent nonpharmacological intervention in MS, with beneficial effects on both functional capacity and the brain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据